Login / Signup

Letter referencing "Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting in glioma patients receiving adjuvant temozolomide".

Kayoko MorioJun WatanabeYasushi Tsujimoto
Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2020)
Keyphrases
  • chemotherapy induced
  • open label
  • phase iii
  • phase ii
  • clinical trial
  • phase ii study
  • early stage
  • study protocol
  • newly diagnosed
  • placebo controlled
  • randomized controlled trial
  • squamous cell carcinoma
  • radiation therapy